Stock(600222)Hot line:010-61006450
About

About Us

Stock(600222)

Leadingpharm was founded in 2005. It is the first company listed on the main board in China (Stock Code: 600222), aiming to promote the development of China's pharmaceutical industry with innovative modes of research, development and service, as well as information technology. Based on the international perspective, Leadingpharm has formed its core competitive advantages, which are internationalization, integration and industrialization. With the mature and perfect drug R & D management system, rich project experience and the team of thousands of senior experts at home and abroad, Leadingpharm has formed a CXO Service System covering the whole industry chain including preclinical research, clinical CRO, CDMO and MAH, and realized the full coverage of innovative drugs, high-end complex preparations, cell gene therapy drugs and other fields, which can provide real one-stop service for global customers.

 

 

More
NEWS

News

  • Company News
2022-04-16

The Clinical Research Protocol Seminar of Insulin-promoting Secretory Peptide Fusion Protein Injection Launched by Beijing Leadingpharm · Deep Blue Ocean (Zhengzhou), CNBG and Lanzhou Institute of CNBG was Held Smoothly

Recently, the Clinical Research Protocol Seminar of Insulin-promoting Secretory Peptide Fusion Protein Injection launched by Beijing Leadingpharm · Deep Blue Ocean (Zhengzhou), CNBG and Lanzhou Institute of CNBG was held smoothly online.

2022-02-26

Alumni Exchange | Alumni of China Europe International Business School (CEIBS) Came to Leadingpharm and Decrypted the Pharmaceutical R & D Enterprise

On February 25, the first stop of the 2022 "Together with You" series of study tour activities initiated by the Alumni Relations Office of CEIBS Beijing Campus, "Decrypting Pharmaceutical R & D Enterprises - Entering Leadingpharm Pharmaceutical Technology", was successfully held in Beijing.

More